Prospective multicentric study. 60 subjects with allergic rhinitis will be enrolled to test the efficacy of nasal hypertonic spray Puressentiel on symptoms of allergic rhinitis and nasal peak flow. Subjects with allergic rhinitis and nasal obstruction will use during 30 days the nasal spray (2 nebulisations /day in each nostril) during 30 days. Rhinitis symptoms questionnaire and nasal inspiratory peak flow will be evaluated before and after 30 days of exposure.
Objective: evaluate the efficiency of a nasal hypertonic spray Puressentiel in subjects with allergic rhinitis and nasal obstruction. Inclusion criteria: subjects with allergic obstructive rhinitis without treatment or remaining symptomatic despite treatment. Duration of exposure: 2 nasal sprays per day (morning and evening) during 30 months. Primary criteria of efficacy: Rhinitis questionnaire. Secondary criteria: Inspiratory nasal peak flow
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
60
One spray of nasal hypertonic spray morning and evening every day during 30 days
Caroline Bonnard
Paris, France
RECRUITINGRhinitis auto questionnaire symptoms
5 questions quoted from 1 (worse) to 5 (best).
Time frame: Measurement at Day 0
Rhinitis auto questionnaire symptoms
5 questions quoted from 1 (worse) to 5 (best).
Time frame: Measurement at Day 30
Nasal inspiratory peak flow
Inspiratory nasal peak flow
Time frame: Measurement at Day 0 and Day 30
Nasal inspiratory peak flow
Inspiratory nasal peak flow
Time frame: Measurement at Day 30
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.